Affiliation:
1. *Division of Pulmonary and Critical Care Medicine and
2. †The Heart and Lung Institute, Ohio State University College of Medicine and Public Health, Columbus, OH 43210; and
3. ‡Progenitor, Inc., Columbus, OH 43210
Abstract
AbstractIgG deposition at tissue sites characteristically leads to macrophage accumulation and organ injury. Although the mechanism by which deposited IgG induces tissue injury is not known, we have recently demonstrated that deposited IgG stimulates the release of IL-8 and monocyte chemoattractant protein-1 from normal human monocytes, which may drive inflammation. Since IgG also induces macrophage accumulation in these diseases, we hypothesized that deposited IgG protects monocytes from apoptosis. As an in vitro model of the effect of deposited IgG on monocyte survival, monocyte apoptosis was studied after FcγR cross-linking. Monocytes cultured on immobilized IgG, which induces FcγR cross-linking, were protected from apoptosis, whereas monocytes cultured with equivalent concentrations of F(ab′)2 IgG or 50 times higher concentrations of soluble IgG, neither of which induces FcγR cross-linking, were not protected. Moreover, this protection was transferable, as supernatants from immobilized IgG-stimulated monocytes protected freshly isolated monocytes from apoptosis and contained functional M-CSF, a known monocyte survival factor. M-CSF mediated the monocyte survival induced by FcγR cross-linking, as neutralizing anti-human M-CSF Abs blocked the monocyte protection provided by either immobilized IgG or IgG-stimulated monocyte supernatants. These findings demonstrate a novel mechanism by which deposited IgG targets tissue macrophage accumulation through FcγR-mediated M-CSF release. This pathway may play an important role in promoting and potentiating IgG-mediated tissue injury.
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Reference36 articles.
1. Muller, M., A. Emmendorffer, M. L. Lohmann-Matthes. 1991. Expansion and high proliferative potential of the macrophage system throughout lifetime of lupus-prone NZB/W and MRL lpr/lpr mice: lack of down-regulation of extramedullary macrophage proliferation in the postnatal period. Eur. J. Immunol. 21: 2211
2. Abd, A. H., N. W. Savage, W. J. Halliday, D. A. Hume. 1991. The role of macrophages in experimental arthritis induced by Streptococcus agalactiae sonicate: actions of macrophage colony-stimulating factor (CSF-1) and other macrophage-modulating agents. Lymphokine Cytokine Res. 10: 43
3. Bloom, R. D., S. Florquin, G. G. Singer, D. C. Brennan, V. R. Kelley. 1993. Colony stimulating factor-1 in the induction of lupus nephritis. Kidney Int. 43: 1000
4. Rossi, G. A., G. W. Hunninghake, O. Kawanami, V. J. Ferrans, C. T. Hansen, R.G. Crystal. 1985. Motheaten mice: an animal model with an inherited form of interstitial lung disease. Am. Rev. Respir. Dis. 131: 150
5. Cline, M. J., R. I. Lehrer, C. Territo, D. W. Golde. 1978. Monocytes and macrophages: functions and diseases. Ann. Intern. Med. 88: 78